Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2002

View Archived Issues

Research reveals mechanism of prostacyclin synthase gene transfer in injured vessels

Further benefit of atorvastatin found in dyslipidemic patients

HCT-1026 diminishes restenosis in an animal model of angioplasty

G-3139 and doxorubicin exhibit favorable interaction in breast cancer model

Cordase as a safe and effective alternative to surgery in Dupuytren's disease

Monotherapy with angiostatic steroid safe in patients with subfoveal AMD

Carotenoids appear to function as ocular antioxidants and to protect against AMD and cataracts

Nymox selects clinical Alzheimer's disease candidate

Posurdex provides higher and more sustained intravitreous drug levels than free dexamethasone

Genentech defines MTD for antiangiogenic antibody fragment in AMD

Antiacne prodrug designed at Tamarkin as potentially safer and more effective than current therapies

Uncoupling protein 3 polypeptides for the treatment of obesity and diabetes

Beta3-adrenoceptor agonists with utility in type 2 diabetes

Antagonists of ETA and ETB receptors with potential utility in circulatory disorders

Gamma-amino acid compounds as GABA analogues with use in epilepsy, etc.

Inhibitors of the ileal bile acid transporter claimed for the treatment of atherosclerosis

Novuspharma describes preparation and use of antitumor compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...